
aTyr Pharma Inc
NASDAQ:ATYR

Income Statement
Earnings Waterfall
aTyr Pharma Inc
Revenue
|
235k
USD
|
Operating Expenses
|
-68.3m
USD
|
Operating Income
|
-68.1m
USD
|
Other Expenses
|
4.2m
USD
|
Net Income
|
-63.8m
USD
|
Income Statement
aTyr Pharma Inc
Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+196%
|
0
+52%
|
8
+1 911%
|
9
+1%
|
9
0%
|
10
+22%
|
2
-77%
|
2
-8%
|
2
-7%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
10
N/A
|
10
N/A
|
10
N/A
|
11
+3%
|
0
-97%
|
1
+67%
|
1
N/A
|
0
-60%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(23)
|
(24)
|
(27)
|
(32)
|
(37)
|
(48)
|
(55)
|
(59)
|
(62)
|
(58)
|
(55)
|
(52)
|
(49)
|
(47)
|
(44)
|
(42)
|
(38)
|
(33)
|
(28)
|
(24)
|
(23)
|
(23)
|
(24)
|
(25)
|
(25)
|
(26)
|
(27)
|
(31)
|
(32)
|
(34)
|
(39)
|
(41)
|
(47)
|
(57)
|
(57)
|
(58)
|
(58)
|
(55)
|
(59)
|
(63)
|
(68)
|
|
Selling, General & Administrative |
(6)
|
(7)
|
(8)
|
(9)
|
(11)
|
(13)
|
(15)
|
(16)
|
(16)
|
(15)
|
(15)
|
(14)
|
(15)
|
(17)
|
(17)
|
(17)
|
(16)
|
(12)
|
(11)
|
(10)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(10)
|
(10)
|
(11)
|
(12)
|
(12)
|
(13)
|
(14)
|
(14)
|
(14)
|
(13)
|
(13)
|
(13)
|
(13)
|
(13)
|
|
Research & Development |
(17)
|
(17)
|
(19)
|
(23)
|
(26)
|
(35)
|
(40)
|
(44)
|
(46)
|
(43)
|
(40)
|
(37)
|
(34)
|
(30)
|
(27)
|
(25)
|
(22)
|
(20)
|
(18)
|
(14)
|
(14)
|
(14)
|
(14)
|
(15)
|
(16)
|
(17)
|
(18)
|
(21)
|
(22)
|
(23)
|
(28)
|
(29)
|
(34)
|
(43)
|
(43)
|
(44)
|
(44)
|
(42)
|
(46)
|
(50)
|
(55)
|
|
Operating Income |
(23)
N/A
|
(24)
-3%
|
(27)
-13%
|
(32)
-21%
|
(37)
-15%
|
(48)
-29%
|
(55)
-15%
|
(59)
-8%
|
(62)
-4%
|
(58)
+6%
|
(55)
+5%
|
(52)
+6%
|
(49)
+6%
|
(47)
+3%
|
(44)
+6%
|
(42)
+4%
|
(38)
+10%
|
(33)
+14%
|
(28)
+13%
|
(24)
+15%
|
(23)
+5%
|
(23)
+0%
|
(15)
+34%
|
(16)
-4%
|
(17)
-6%
|
(16)
+6%
|
(25)
-57%
|
(29)
-17%
|
(30)
-4%
|
(34)
-12%
|
(39)
-15%
|
(41)
-5%
|
(47)
-14%
|
(46)
+1%
|
(47)
-1%
|
(48)
-2%
|
(47)
+2%
|
(55)
-17%
|
(59)
-7%
|
(63)
-6%
|
(68)
-9%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(0)
|
(1)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Non-Reccuring Items |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
4
|
5
|
5
|
5
|
4
|
|
Pre-Tax Income |
(24)
N/A
|
(24)
-3%
|
(27)
-12%
|
(33)
-20%
|
(38)
-14%
|
(48)
-28%
|
(55)
-15%
|
(59)
-8%
|
(62)
-4%
|
(58)
+6%
|
(55)
+5%
|
(52)
+6%
|
(49)
+5%
|
(48)
+2%
|
(45)
+6%
|
(44)
+4%
|
(40)
+9%
|
(35)
+13%
|
(30)
+13%
|
(25)
+15%
|
(24)
+6%
|
(24)
+1%
|
(16)
+33%
|
(16)
-4%
|
(17)
-6%
|
(16)
+7%
|
(25)
-55%
|
(29)
-16%
|
(30)
-4%
|
(34)
-12%
|
(39)
-15%
|
(41)
-5%
|
(46)
-14%
|
(45)
+2%
|
(45)
+0%
|
(45)
+0%
|
(43)
+4%
|
(50)
-17%
|
(54)
-7%
|
(58)
-7%
|
(64)
-10%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(24)
|
(24)
|
(27)
|
(33)
|
(38)
|
(48)
|
(55)
|
(59)
|
(62)
|
(58)
|
(55)
|
(52)
|
(49)
|
(48)
|
(45)
|
(44)
|
(40)
|
(35)
|
(30)
|
(25)
|
(24)
|
(24)
|
(16)
|
(16)
|
(17)
|
(16)
|
(25)
|
(29)
|
(30)
|
(34)
|
(39)
|
(41)
|
(46)
|
(45)
|
(45)
|
(45)
|
(43)
|
(50)
|
(54)
|
(58)
|
(64)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
Net Income (Common) |
(24)
N/A
|
(25)
-2%
|
(28)
-11%
|
(33)
-19%
|
(38)
-14%
|
(48)
-28%
|
(55)
-15%
|
(59)
-8%
|
(62)
-4%
|
(58)
+6%
|
(55)
+5%
|
(52)
+6%
|
(49)
+5%
|
(48)
+2%
|
(45)
+6%
|
(44)
+4%
|
(40)
+9%
|
(35)
+13%
|
(30)
+13%
|
(25)
+15%
|
(24)
+6%
|
(24)
+1%
|
(16)
+33%
|
(16)
-4%
|
(17)
-6%
|
(16)
+6%
|
(25)
-55%
|
(29)
-16%
|
(30)
-4%
|
(34)
-12%
|
(39)
-15%
|
(41)
-5%
|
(46)
-14%
|
(45)
+2%
|
(45)
+0%
|
(45)
+0%
|
(43)
+4%
|
(50)
-17%
|
(54)
-7%
|
(58)
-7%
|
(64)
-10%
|
|
EPS (Diluted) |
-15.09
N/A
|
-15.38
-2%
|
-17.14
-11%
|
-19.52
-14%
|
-22.22
-14%
|
-28.38
-28%
|
-32.58
-15%
|
-35.06
-8%
|
-36.51
-4%
|
-34.2
+6%
|
-32.53
+5%
|
-30.52
+6%
|
-26.73
+12%
|
-26.16
+2%
|
-21.36
+18%
|
-20.51
+4%
|
-18.59
+9%
|
-16.13
+13%
|
-12.41
+23%
|
-7.83
+37%
|
-6.22
+21%
|
-7.03
-13%
|
-2.28
+68%
|
-1.74
+24%
|
-1.78
-2%
|
-1.77
+1%
|
-1.78
-1%
|
-1.8
-1%
|
-1.65
+8%
|
-1.77
-7%
|
-1.39
+21%
|
-1.45
-4%
|
-1.61
-11%
|
-1.6
+1%
|
-1.07
+33%
|
-0.81
+24%
|
-0.74
+9%
|
-0.94
-27%
|
-0.81
+14%
|
-0.8
+1%
|
-0.84
-5%
|